Cybersecurity

Blood Tests Could Provide Early Warning of Alzheimers Disease

Ali Nemati3 days ago23 sec read15 views

Researchers have developed a predictive model using p-tau217 protein levels in blood to estimate when individuals will begin showing symptoms of Alzheimer's disease, potentially years before cognitive decline is apparent. This early detection could allow for better planning and management by patients and families, and also streamline clinical trials for preventive treatments.

Read the full article at Hackaday

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Comments

STAT+: Pharmalittle: We're reading about Trump and drug prices, biotechs pushing back, and more

Trump is receiving more credit than Biden for efforts to lower drug prices in the U.S., according to a KFF poll, despite both administrations prioritizing this issue; biotech companies are openly opposing Trump's plan to cap drug prices, arguing it c...

Ali Nemati

AI & Machine Learning20 hours ago25 sec read

A dietitian's favorite quick, high-protein recipes, including the turkey skillet she makes every week

Rachael DeVaux, a registered dietitian and author of "The High-Protein Plate," shared recipes for quick, high-protein meals including overnight oats, chicken salad, and a turkey skillet. These meals aim to make eating 100 grams of protein daily enjoy...

Ali Nemati

AI & Machine Learning1 day ago28 sec read

How I Built Nucleon CLI: One Tool to Replace My Entire Development Workflow

The author created Nucleon CLI to streamline and unify their development workflow by integrating multiple tools into one intelligent interface. This tool automates project setup, code analysis, deployment, and environment diagnostics for various fram...

Ali Nemati

Biotech & Pharma1 day ago28 sec read

STAT+: Pharmalittle: We're reading about telehealth prescribers, a Lilly push against compounding, and more

The FDA is cracking down on telehealth companies marketing compounded versions of weight loss drugs by warning them against false claims and scrutinizing their clinical affiliations, while a key U.S. federal vaccine advisory panel has abandoned effor...

Ali Nemati

Health & Medicine1 day ago23 sec read

STAT+: Is Aldeyra Therapeutics waving red flags with consequences?

Aldeyra Therapeutics has raised concerns about short sellers ahead of an FDA approval decision, signaling potential risks for investors; this highlights the scrutiny biotech companies face from market skeptics as they await critical regulatory milest...

Ali Nemati

Blood Tests Could Provide Early Warning of Alzheimers Disease

Related Articles

STAT+: Pharmalittle: We're reading about Trump and drug prices, biotechs pushing back, and more

A dietitian's favorite quick, high-protein recipes, including the turkey skillet she makes every week

How I Built Nucleon CLI: One Tool to Replace My Entire Development Workflow

STAT+: Pharmalittle: We're reading about telehealth prescribers, a Lilly push against compounding, and more

STAT+: Is Aldeyra Therapeutics waving red flags with consequences?